@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

<http://hl7.org/fhir/uv/clinical-study-protocol/ResearchStudy/JPMA0001-jpn> a fhir:ResearchStudy ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "JPMA0001-jpn"] ; # 
  fhir:meta [
     fhir:profile ( [
       fhir:v "http://hl7.org/fhir/uv/clinical-study-protocol/StructureDefinition/m11-research-study-profile"^^xsd:anyURI ;
       fhir:l <http://hl7.org/fhir/uv/clinical-study-protocol/StructureDefinition/m11-research-study-profile>
     ] )
  ] ; # 
  fhir:language [ fhir:v "en"] ; # 
  fhir:text [
     fhir:status [ fhir:v "extensions" ] ;
     fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p class=\"res-header-id\"><b>Generated Narrative: ResearchStudy JPMA0001-jpn</b></p><a name=\"JPMA0001-jpn\"> </a><a name=\"hcJPMA0001-jpn\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Language: en</p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-m11-research-study-profile.html\">M11 Research Study Profile</a></p></div><blockquote><p><b>M11 Research Study Extension</b></p><ul><li>originalProtocol: <span title=\"Codes:{http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl C218485}\">Protocol Not Amended</span></li><li>versionDate: 2026-01-14</li></ul></blockquote><p><b>Narrative Elements</b>: <a href=\"Composition-JPMA0001-Section5-jpn.html\">Composition JPMA0001 Protocol Narrative Sections 5.2 and 5.3 (Inclusion/Exclusion Ctriteria)</a></p><p><b>identifier</b>: Sponsor Identifier/JPMA001 (use: usual, )</p><p><b>version</b>: 2.0</p><p><b>title</b>: 経口血糖降下薬単剤による治療では血糖コントロール不十分な2型糖尿病患者を対象として，JPMA001を併用投与した時の安全性および有効性を検討する多施設共同，52週間，ランダム化，並行群間試験</p><h3>Labels</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Value</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://hl7.org/fhir/title-type short-title}\">Short title</span></td><td>2型糖尿病患者への投与</td></tr></table><p><b>status</b>: Active</p><p><b>phase</b>: <span title=\"Codes:{http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl C15602}\">Phase III Trial</span></p><h3>Recruitments</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Eligibility</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"Group-JPMA0001-Criteria-JPN.html\">Group Japanese Protocol from Vulcan UDP Eligibility Criteria</a></td></tr></table></div>"^^rdf:XMLLiteral ]
  ] ; # 
  fhir:extension ( [
     fhir:extension ( [
       fhir:url [
         fhir:v "originalProtocol"^^xsd:anyURI ;
         fhir:l fhir:originalProtocol
       ] ;
       fhir:value [
         a fhir:CodeableConcept ;
         fhir:coding ( [
           fhir:system [
             fhir:v "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl"^^xsd:anyURI ;
             fhir:l <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl>
           ] ;
           fhir:code [ fhir:v "C218485" ] ;
           fhir:display [ fhir:v "Protocol Not Amended" ]
         ] )
       ]
     ] [
       fhir:url [
         fhir:v "versionDate"^^xsd:anyURI ;
         fhir:l fhir:versionDate
       ] ;
       fhir:value [
         a fhir:Date ;
         fhir:v "2026-01-14"^^xsd:date
       ]
     ] ) ;
     fhir:url [
       fhir:v "http://hl7.org/fhir/uv/clinical-study-protocol/StructureDefinition/m11-research-study"^^xsd:anyURI ;
       fhir:l <http://hl7.org/fhir/uv/clinical-study-protocol/StructureDefinition/m11-research-study>
     ]
  ] [
     fhir:url [
       fhir:v "http://hl7.org/fhir/uv/clinical-study-protocol/StructureDefinition/narrative-elements"^^xsd:anyURI ;
       fhir:l <http://hl7.org/fhir/uv/clinical-study-protocol/StructureDefinition/narrative-elements>
     ] ;
     fhir:value [
       a fhir:Reference ;
       fhir:l <http://hl7.org/fhir/uv/clinical-study-protocol/Composition/JPMA0001-Section5-jpn> ;
       fhir:reference [ fhir:v "Composition/JPMA0001-Section5-jpn" ]
     ]
  ] ) ; # 
  fhir:identifier ( [
     fhir:use [ fhir:v "usual" ] ;
     fhir:type [
       fhir:text [ fhir:v "Sponsor Identifier" ]
     ] ;
     fhir:system [
       fhir:v "https://exemplarSponsor.com/sponsor-identifier"^^xsd:anyURI ;
       fhir:l <https://exemplarSponsor.com/sponsor-identifier>
     ] ;
     fhir:value [ fhir:v "JPMA001" ]
  ] ) ; # 
  fhir:version [ fhir:v "2.0"] ; # 
  fhir:title [ fhir:v "経口血糖降下薬単剤による治療では血糖コントロール不十分な2型糖尿病患者を対象として，JPMA001を併用投与した時の安全性および有効性を検討する多施設共同，52週間，ランダム化，並行群間試験"] ; # 
  fhir:label ( [
     fhir:type [
       fhir:coding ( [
         fhir:system [
           fhir:v "http://hl7.org/fhir/title-type"^^xsd:anyURI ;
           fhir:l <http://hl7.org/fhir/title-type>
         ] ;
         fhir:code [ fhir:v "short-title" ] ;
         fhir:display [ fhir:v "Short title" ]
       ] )
     ] ;
     fhir:value [ fhir:v "2型糖尿病患者への投与" ]
  ] ) ; # 
  fhir:status [ fhir:v "active"] ; # 
  fhir:phase [
     fhir:coding ( [
       fhir:system [
         fhir:v "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl"^^xsd:anyURI ;
         fhir:l <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl>
       ] ;
       fhir:code [ fhir:v "C15602" ] ;
       fhir:display [ fhir:v "Phase III Trial" ]
     ] )
  ] ; # 
  fhir:recruitment [
     fhir:eligibility [
       fhir:l <http://hl7.org/fhir/uv/clinical-study-protocol/Group/JPMA0001-Criteria-JPN> ;
       fhir:reference [ fhir:v "Group/JPMA0001-Criteria-JPN" ]
     ]
  ] . # 

<http://hl7.org/fhir/uv/clinical-study-protocol/Composition/JPMA0001-Section5-jpn> a fhir:Uv .

<http://hl7.org/fhir/uv/clinical-study-protocol/Group/JPMA0001-Criteria-JPN> a fhir:Uv .

# -------------------------------------------------------------------------------------

